02 October 2020>: Original Paper
Safe Long-Term Outcome After Kidney Donation in Older Donors: A Single-Center Experience
Antonia Schuster 1ABCDEF* , Paula Franke 1BCDE , Louisa Steines 1BCDE , Daniel Zecher 1BCDE , Christina Hackl 2BCDE , Jens Werner 2BCDE , Tobias Bergler 1ABCDEF* , Bernhard Banas 1ABCDE*DOI: 10.12659/AOT.924235
Ann Transplant 2020; 25:e924235
Table 1 Baseline data and 10 years of follow-up stratified by age. * p≤0.05.
Baseline (n=214) | 1 year follow-up (n=200) | 5 years follow-up (n=127) | 10 years follow-up (n=70) | |||||
---|---|---|---|---|---|---|---|---|
<65 years (n=182) | ≥65 years (n=32) | <65 years (n=170) | ≥65 years (n=30) | <65 years (n=108) | ≥65 years (n=19) | <65 years (n=59) | ≥65 years (n=11) | |
Gender (n) | M: F 70: 112 | M: F 12: 20 | ||||||
Age | ||||||||
BMI (kg/m) | 26.0±3.5 | 26.3±3.0 | 25.7±4.3 | 25.6±0.8 | 27.5±4.5 | 26.3±2.3 | 31.8±8.5 | 25.3±3.5 |
Creatinine (mg/dl) | 0.8±0.2 | 0.8±0.2 | 1.2±0.2 | 1.3±0.3 | 1.1±0.2 | 1.2±0.3 | ||
Urea (mg/dl) | 29.5±7.3 | 31.7±11.0 | 38.8±10.1 | 43,9±9.4 | 36.7±9.9 | 45.4±11.9 | ||
eGFR CKD-EPI | ||||||||
Albuminuria (mg/l) | 10.5±27.8 | 7.7±6.1 | 14.3±40.0 | 17.9±41.4 | 10.3±22.7 | 6.3±4.7 | 5.6±1.9 | 5.0±0 |
Proteinuria (mg/l) | 54.3±33.1 | 52.3±32.3 | 71.3±88.8 | 57.7±39.8 | 50.2±16.8 | 50.0±0 | 47.3±10.2 | 50±0 |
Hemoglobin | 14.3±1.2 | 14.3±0.9 | 14.1±1.1 | 13.7±0.9 | 14.1±1.2 | 13.9±0.8 | 13.9±1.0 | 14.2±0.8 |
HbA1c | 5.3±0.5 | 6.1±0.4 | 6.0±0.9 | 5.2±0 | 6.4±0.7 | 6.0±0 | ||
Medication (n) | 1.0±1.9 | 2.0±2.2 | 1.8±1.8 | 4.6±3.1 | 2.3±2.3 | 4.2±2.6 | ||
RRsys (mmHg) | 124±9.5 | 125±11.5 | 128±15.1 | 136±24.1 | 129±20.0 | 137±23.0 | 134±19.4 | 132±12.6 |
RRdia (mmHg) | 80±9.1 | 78±8.9 | 80±9.4 | 77±8.6 | 82±8.5 | 76±6.6 |